Buchumschlag

Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID‐19 Under the Emergency Use Authorization

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Qi Liu, Raj Nair, Ruihao Huang, Hao Zhu, Austin Anderson, Ozlem Belen, Van Tran, Rebecca Chiu, Karen Higgins, Jianmeng Chen, Lei He, Suresh Doddapaneni, Shiew‐Mei Huang, Nikolay P. Nikolov, Issam Zineh
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Clinical Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Model‐Informed Drug Development‐Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non‐Radiographic Axial Spondyloarthritis
von: Dipak S. Pisal, et al.
Veröffentlicht: (2024)

The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway
von: Rajanikanth Madabushi, et al.
Veröffentlicht: (2024)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins
von: Yow‐Ming C. Wang, et al.
Veröffentlicht: (2024)

In Memoriam Arthur J. Atkinson, Jr. (1938–2024)
von: Juan J. L. Lertora, et al.
Veröffentlicht: (2024)

Insights into PK ‐Based Bridging for Products Using a Common Autoinjector Platform: A Review of 16 Autoinjectors in 14 Biological License Applications
von: Zhe Li, et al.
Veröffentlicht: (2026)

The Future of Clinical Translational Pharmacology
von: Matthew L. Rizk, et al.
Veröffentlicht: (2026)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients—Authors' reply
von: Linda Henry, et al.
Veröffentlicht: (2024)

Editorial: Decoding Gut Failure in Cirrhosis—Villin‐1 and the Emergence of a Seventh Organ Failure. Authors' Reply
von: David Tornai, et al.
Veröffentlicht: (2026)

Letter: Advancing Serologic Classification in Indeterminate Chronic Hepatitis B Through Dynamic and Integrated Frameworks—Authors' Reply
von: Rui Huang, et al.
Veröffentlicht: (2025)

Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population. Authors' Reply
von: Daniel Q. Huang, et al.
Veröffentlicht: (2026)

Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply
von: Jiong Yu, et al.
Veröffentlicht: (2024)

Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply
von: Jian Wang, et al.
Veröffentlicht: (2025)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply
von: Eunice X. X. Tan, et al.
Veröffentlicht: (2024)

Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Authors' Reply
von: Sara Ellegaard Paaske, et al.
Veröffentlicht: (2026)

Editorial: Cephalosporin‐Induced Liver Injury—Interesting but Tricky. Authors' Reply
von: Raj Vuppalanchi, et al.
Veröffentlicht: (2025)

Editorial: Beyond Viral Eradication—Cardiometabolic Risk and Cardiovascular Outcomes After SVR in Chronic Hepatitis C. Authors' Reply
von: Pei‐Chien Tsai, et al.
Veröffentlicht: (2026)

From Models to Medicines: A Narrative History and Regulatory Perspective on the Translational Impact of Model‐Informed Drug Development ( MIDD )
von: Issam Zineh
Veröffentlicht: (2026)

Editorial: Understanding How Social Determinants of Health Impact Mortality in MASLD —Insights From a National Analysis. Authors' Reply
von: Donghee Kim, et al.
Veröffentlicht: (2025)

Author Index
Veröffentlicht: (2025)

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply
von: Ryan M. Mathias, et al.
Veröffentlicht: (2025)

Editorial: HBeAg ‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations. Authors' Reply
von: Yuxin Chen, et al.
Veröffentlicht: (2025)

Comparison of Rocuronium and Succinylcholine for First‐Attempt Intubation Success in the Emergency Department
von: Helen Y. Wang, et al.
Veröffentlicht: (2024)

Hydrogel Delivering All‐Trans Retinoic Acid to Regulate Macrophage Polarization to Enhance Chemo‐Immunotherapy for Gastric Cancer
von: Ruobing Bai, et al.
Veröffentlicht: (2025)

Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)
von: Andrew M. Riselli, et al.
Veröffentlicht: (2025)

Editorial: Quantity is important! Authors' reply
von: Marika Rudler, et al.
Veröffentlicht: (2024)

Editorial: Beyond Clinical Trials—Real‐World Data Suggest Usefulness of GLP‐1 RAs in MASLD Treatment. Authors' Reply
von: Chia‐Chih Kuo, et al.
Veröffentlicht: (2025)

Genetic Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance and Its Associated Viral Markers
von: Jun Tao, et al.
Veröffentlicht: (2026)

Intra‐Articular Injectable Chitosan‐PVA Hydrogel Ingrained With Gallic Acid Loaded Mesoporous Silica Nanoparticles for Pain Relief and Cartilage Regeneration in Obese Osteoarthritic Rats
von: Syed Nasar Rahaman, et al.
Veröffentlicht: (2026)

Comparative Analysis of Post‐Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023
von: Diana Mandslay, et al.
Veröffentlicht: (2024)

Letter: Irritable bowel syndrome and antibiotics—Authors' reply
von: Kyle Staller, et al.
Veröffentlicht: (2024)

Editorial: Getting to the Heart of the Matter in IBD—Authors' Reply
von: Ramin Ebrahimi, et al.
Veröffentlicht: (2025)

Editorial: Another brick in the CDST wall: Authors' reply
von: Kyuwon Kim, et al.
Veröffentlicht: (2024)

Editorial: Balancing the Yin and Yang of Alcohol‐Associated Liver Disease—Integrating Pathophysiology, Liver‐Directed Therapy and Addiction Management
von: Raj Vuppalanchi, et al.
Veröffentlicht: (2025)

Editorial: Crystalising the burden of steatotic liver disease—Authors' reply
von: Carolin V. Schneider, et al.
Veröffentlicht: (2024)

Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply
von: Jianhui Zhao, et al.
Veröffentlicht: (2024)

Editorial: To Stop or Not to Stop, Is It Still a Question? Authors' Reply
von: Jeongkuk Seo, et al.
Veröffentlicht: (2024)

Editorial: Association of Antibiotic Exposure With Microscopic Colitis—Authors' Reply
von: Máté Szilcz, et al.
Veröffentlicht: (2025)

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
von: Benedikt Silvester Hofer, et al.
Veröffentlicht: (2024)

Editorial: Predicting Hepatocellular Cancer in Clinical Practice. Authors' Reply
von: Shuaibing Ying, et al.
Veröffentlicht: (2026)

Editorial: Can We Prevent Inflammatory Bowel Disease? Authors' Reply
von: Fai Fai Ho, et al.
Veröffentlicht: (2025)